Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Physiology (Bethesda). 2022 Nov 1;37(6):0. doi: 10.1152/physiol.00016.2022. Epub 2022 Aug 9.
Inborn errors of immunity (IEI) are a heterogeneous group of disorders affecting immune host defense and immunoregulation. Considering the predisposition to develop severe and chronic infections, it is crucial to understand the clinical evolution of COVID-19 in IEI patients. This review analyzes clinical outcomes following SARS-CoV-2 infection, as well as response to COVID-19 vaccines in patients with IEI.
先天性免疫缺陷（IEI）是一组影响宿主免疫防御和免疫调节的异质性疾病。鉴于易发生严重和慢性感染，了解 IEI 患者 COVID-19 的临床演变至关重要。本综述分析了 SARS-CoV-2 感染后的临床结局，以及 IEI 患者对 COVID-19 疫苗的反应。
